Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT

2 de junio de 2026 actualizado por: MELTEM KALAYCI, Hasan Kalyoncu University

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSIVE CARE PATIENTS UNDER MECHANICAL VENTILATION SUPPORT ON PAIN AND PHYSIOLOGICAL PARAMETERS.

The aim of this study is to examine the effect of Su Jok Therapy, applied to patients receiving mechanical ventilation support in the intensive care unit, on pain and physiological parameters.

Descripción general del estudio

Descripción detallada

Mechanical ventilation (MV), one of the most common treatment methods in Intensive Care Units (ICUs), is a critical treatment approach to ensure adequate respiratory function in patients.

Although mechanical ventilation is a life-saving treatment method in ICUs, it can cause many physiological and psychological problems for patients. Furthermore, excessive exposure to physical, psychosocial, and environmental stressors can affect the patient's autonomic response and vital parameters (tachycardia, hypertension, tachypnea), leading to hemodynamic instability

The World Health Organization (WHO) defines Integrated, Complementary, and Alternative Medicine Practices as the provision of healthcare services that are not part of a country's own tradition or conventional medicine and are not fully integrated into the dominant healthcare system In intensive care patients, non-pharmacological methods such as aromatherapy, music therapy, massage, reflexology, acupressure, and Reiki are used as complementary and alternative treatments. Su Jok, one of these non-pharmacological methods, is an alternative treatment method based on traditional Korean medicine. Su Jok is a treatment method that uses the feet and hands, derived from the Korean words Su (hand) and Jok (foot). In the literature, it is argued that nurses can apply Su Jok therapy as an integrative method in symptom management due to its simplicity of application, lack of side effects, and non-invasiveness, which is similar to the philosophy of integrative nursing. Looking at the literature, very few studies on Su Jok therapy have been found. No studies have been found in the literature regarding the effect of Su Jok therapy on intensive care patients and patients on mechanical ventilation support.

Tipo de estudio

Intervencionista

Inscripción (Actual)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Kahramanmaraş
      • Kahramanmaraş, Kahramanmaraş, Turquía (Türkiye), 46050
        • Kahramanmaraş

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Patients who are in intensive care,

    • Patients receiving IMV support,
    • Patients who were admitted to the ICU from the start date of the study and are planned to be monitored for at least 24 hours,
    • Patients without any problems in the area where Su-Jok will be applied,
    • Patients with GCS > 3, RASS between +1 and +4, BPS > 3

Exclusion Criteria:

  • • Patients in the ward,

    • Patients with any problems such as fungal infections or wounds in the area where Su Jok will be applied,
    • Patients with a GCS of 3,
    • Patients not receiving IMV support will not be included in the study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Grupo de control
No se aplicará ninguna intervención al grupo de control.
Experimental: Intervetion group
In the intervention group, su-jok seed therapy will be applied to the su-jok reflection zones on the hands.
In the intervention group, the reflex zones on the hands were identified with a probe. Buckwheat seeds were fixed to these areas with adhesive tape and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.
Comparador de placebos: Placebo group
In the placebo group, su-jok seed therapy will be applied to areas on the hands that are different from the reflection zones.
In the placebo group, reflex zones on the hand were identified using a probe. Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Systolic Blood Pressure
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Hemodynamic response measured by systolic blood pressure
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate (Pulse Rate)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart rate measured in beats per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygen Saturation (SpO₂)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Peripheral oxygen saturation
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Body Temperature
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Core body temperature
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Respiratory Rate
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Number of breaths per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Richmond Agitation-Sedation Scale (RASS)
Periodo de tiempo: baseline, 1 hour, 4 hours after intervention
Negative scores indicate sedation, positive scores indicate agitation
baseline, 1 hour, 4 hours after intervention
Behavioral Pain Scale (BPS)
Periodo de tiempo: baseline, 1 hour, 4 hours after intervention
Higher scores indicate more severe pain
baseline, 1 hour, 4 hours after intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Hemodynamic Stability Index (Systolic/Diastolic Blood Pressure Change)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Change in systolic and diastolic blood pressure from baseline to post-intervention measurements.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygenation Trend (SpO₂ Change Over Time)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in peripheral oxygen saturation over the intervention period.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate Variability (Clinical Pulse Trend)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in heart rate measured in beats per minute during and after intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Sedation-Agitation Level Stability (RASS Trend)
Periodo de tiempo: baseline, 1 hour, 4 hours after intervention
Changes in Richmond Agitation-Sedation Scale (RASS) scores over time indicating sedation or agitation level.
baseline, 1 hour, 4 hours after intervention
Pain Intensity Change (Behavioral Pain Scale Trend)
Periodo de tiempo: baseline, 1 hour, 4 hours after intervention
Changes in Behavioral Pain Scale (BPS) scores indicating pain severity over time.
baseline, 1 hour, 4 hours after intervention
Respiratory Stability (Respiratory Rate Change)
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in respiratory rate indicating respiratory stability during intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Temperature Stability
Periodo de tiempo: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in body temperature over time following intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Non-pharmacological Intervention Effectiveness (Overall Clinical Stability Score)
Periodo de tiempo: baseline, 4 hours after intervention
Composite assessment of physiological stability based on vital signs and sedation/pain scores.
baseline, 4 hours after intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Silla de estudio: NERMİN OLGUN, Prof. Dr., Hasan Kalyoncu University
  • Investigador principal: MELTEM KALAYCI, Hasan Kalyoncu University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de marzo de 2025

Finalización primaria (Actual)

1 de marzo de 2025

Finalización del estudio (Actual)

1 de noviembre de 2025

Fechas de registro del estudio

Enviado por primera vez

30 de diciembre de 2025

Primero enviado que cumplió con los criterios de control de calidad

2 de junio de 2026

Publicado por primera vez (Actual)

8 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

8 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • HKU-LEE-MK-01

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir